BioSpace News Archive

Medtronic plc today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its INVOS™ 7100 cerebral/somatic oximetry system for children from birth through age 18.

HemoShear Therapeutics, Inc. has appointed Patrick Horn , MD, PhD, as Chief Medical Officer, effective January 1, 2022.

Mind Cure Health Inc. announces the appointment of Doron Sagman , MD, FRCPC, as the Company’s new Chief Medical Officer.

Lead investigators from clinical trials evaluating eprenetapopt in patients with TP53 mutant MDS or AML presented positive, updated data at the 2021 ASH Annual Meeting.

Affinia Therapeutics today announced the appointment of Thomas (Tommy) Leggett as Chief Financial Officer (CFO).

electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today provided an update on the ongoing clinical research to assess the potential of gammaCore (non-invasive vagal nerve stimulation; nVNS) to treat Post Traumatic Stress Disorder (“PTSD”).

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the first patient with recurrent glioblastoma (GBM) was treated with the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® at Providence Saint John’s Health Center in Santa Monica, CA.

Ascendis Pharma A/S (Nasdaq: ASND) today plans to provide an update on two of its investigational endocrinology rare disease development programs, TransCon PTH for hypoparathyroidism, and TransCon CNP for achondroplasia, and on one of its investigational oncology product candidates, TransCon TLR7/8 Agonist at the Company’s virtual R&D Program Update.

Sirius Medical, a leader in tumor navigation technology, announced today the closing of its second round of series A financing.

Today the American Academy of Physical Medicine and Rehabilitation (AAPM&R) released the next two parts in a series of consensus statements with practical guidance for clinicians treating patients suffering from breathing discomfort or cognitive symptoms, two common symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), or Long COVID.